A detailed history of Coppell Advisory Solutions LLC transactions in Organon & Co. stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 57 shares of OGN stock, worth $856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57
Previous 57 -0.0%
Holding current value
$856
Previous $1.18 Million 7.37%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $54 - $86
5 Added 9.62%
57 $822,000
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $66 - $95
-4 Reduced 7.14%
52 $1.45 Million
Q2 2023

Aug 17, 2023

BUY
$19.27 - $24.63 $1,079 - $1,379
56 New
56 $1.16 Million
Q1 2023

May 19, 2023

SELL
$21.42 - $32.08 $1,113 - $1,668
-52 Closed
0 $0
Q4 2022

May 19, 2023

BUY
$23.31 - $28.61 $1,212 - $1,487
52 New
52 $1.45 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.82B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.